Navigation Links
Concentric Medical Announces Enrollment Milestone for Merci Registry
Date:5/14/2009

MOUNTAIN VIEW, Calif., May 14 /PRNewswire/ -- Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced the enrollment of the 500th patient in its Merci Registry, a real-world, international, post-market study of its innovative product, the Merci Retrieval System(TM). The Registry has enrolled patients from over 30 sites worldwide and is continuing to enroll patients. The Registry is the largest repository of data on mechanical intervention in acute ischemic stroke patients.

In June 2007, Concentric Medical launched the Merci Registry to collect data to gain a better understanding of the best practices surrounding use of mechanical intervention in acute ischemic stroke patients. Concentric Medical continues to demonstrate scientific leadership in acute ischemic stroke intervention with this Registry, as well as the two peer-reviewed and published clinical trials MERCI and Multi MERCI. In addition, Concentric is currently planning RETRIEVE, a randomized controlled trial comparing outcomes in patients treated with the Merci Retrieval System to medically treated patients. The Registry and the two published trials include clinical data on over 800 ischemic stroke patients treated with the Merci Retrieval System.

The Merci Registry has captured a wide variety of data, including acute procedural data, patient care protocols, and longer term outcomes. The acute procedural data, such as recanalization rates and procedural steps, play a critical role in Concentric Medical's ability to continually improve the technical success and ease of use of the Merci Retrieval System. Participating physicians and Concentric Medical are analyzing patient care protocols and longer term outcomes to further the stroke community's understanding of best practices for the acute care and management of stroke victims. The first analyses of these data are expected to be completed and presented later this year.

Wade S. Smith, MD, PhD, Professor of Neurology at University of California San Francisco, said, "The Merci Registry is an invaluable tool that will provide physicians who treat stroke with important information on the benefits offered by mechanical intervention, as well as insight into how best to care for patients who suffer from this devastating disease. Data reflecting real-world experience complements data derived from clinical trials because it represents more closely how patients are being cared for in the community at large. Because we are still in the early phases of acute treatment of ischemic stroke, it will also serve as a platform for us to ask additional questions and may ultimately help shape the future of research and patient care."

Stroke is the third leading cause of death in the United States and the leading cause of serious long-term disability with close to 800,000 strokes expected to occur in 2009. Ischemic stroke represents over 85% of strokes and occurs when a blockage or clot develops in one of the arteries supplying blood to the brain. In 2004 the FDA cleared Concentric Medical's Merci Retrieval System for use in patients who are ineligible for IV-tPA or fail to respond to IV-tPA therapy. This new system offered physicians and patients a long-awaited option for stroke intervention and created a departure from the historic method of caring for stroke patients.

About Concentric Medical

Concentric Medical is located in Mountain View, California and is the global leader in the endovascular treatment of acute ischemic stroke. The company manufactures and markets the Merci Retrieval System(TM), a set of minimally invasive devices that are delivered into the brain to restore blood flow by removing blood clots that cause ischemic stroke. The Merci Retrieval System is available in over 300 leading stroke centers around the world, and has been the subject of two successful clinical trials, MERCI and Multi MERCI. Concentric Medical estimates that over 10,000 patients have been treated with its devices. For more information about Concentric Medical, please visit www.concentric-medical.com.

    Media Contact: Mike Dineen, VP of Marketing
    +1 650-938-2100
    strokeinfo@concentric-medical.com


'/>"/>
SOURCE Concentric Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Concentric Medical Announces European Release of Expanded Family of Neurovascular Retrievers for use in Stroke Patients
2. Concentric Launches New Consumer Division, Names Mike Devlin EVP, Managing Director
3. Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding
4. Maria Sainz Named President and CEO of Concentric Medical
5. Concentric Named to List of Top 60 Healthcare Agencies in U.S.
6. Concentric Medical Launches Distal Access Catheter
7. Concentric Medical Reaches Important Stroke Milestone
8. Concentric Medical Expands Product Offering in Neuro Access
9. MSU engineering team designs innovative medical device
10. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
11. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: